Literature DB >> 3485441

Morphological and isoenzymatic differentiation of B-chronic lymphocytic leukaemia cells induced by phorbolester.

H G Drexler, M Klein, N Bhoopalam, G Gaedicke, J Minowada.   

Abstract

Fresh leukaemia cells from the peripheral blood of 6 patients with B-chronic lymphocytic leukaemia (CLL) were cultured in the continuous presence of the phorbolester 12-O-tetradecanoylphorbol 13-acetate (TPA) for in vitro induction of differentiation. Upon treatment with TPA the cells showed distinct morphological changes consisting of cytoplasmic and nuclear enlargement, vacuolisation and protrusion of cytoplasm, eccentric location of nuclei with perinuclear clear zones, and oval to elongated cell forms. Isoenzyme profiles of the enzymes carboxylic esterase, acid phosphatase, hexosaminidase and lactate dehydrogenase (LDH) were analysed by isoelectric focusing on polyacrylamide gels. An increase in the number and in the staining intensity of isoenzymes were observed for all 4 enzymes in the TPA-exposed cells indicating a maturation along the B cell pathway. TPA triggered the new expression of the tartrate-resistant acid phosphatase isoenzyme, a marker of hairy cell leukaemia (HCL) cells, and of the hexosaminidase I isoenzyme, a marker of multiple myeloma cells. The induced phenotypic changes are suggestive of differentiation to stages corresponding to those of HCL cells or 'pre-plasma cells'.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485441      PMCID: PMC2001325          DOI: 10.1038/bjc.1986.33

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  Tartrate-resistant acid phosphatase isoenzyme in the reticulum cells of leukemic reticuloendotheliosis.

Authors:  L T Yam; C Y Li; K W Lam
Journal:  N Engl J Med       Date:  1971-02-18       Impact factor: 91.245

2.  Isoenzyme studies in human leukemia-lymphoma cell lines--1. Carboxylic esterase.

Authors:  H G Drexler; G Gaedicke; J Minowada
Journal:  Leuk Res       Date:  1985       Impact factor: 3.156

3.  Differentiation of chronic lymphocytic leukemia cells after in vitro treatment with Epstein-Barr virus or phorbol ester. I. Immunologic and morphologic studies.

Authors:  M J Deegan; K Maeda
Journal:  Am J Hematol       Date:  1984       Impact factor: 10.047

4.  In vitro differentiation of chronic lymphocytic leukaemia cells with a small pre-B-like phenotype.

Authors:  J Gordon; P Aman; H Mellstedt; P Biberfeld; G Klein
Journal:  Leuk Res       Date:  1983       Impact factor: 3.156

5.  Phenotypic modulation of chronic lymphocytic leukemia cells by phorbol ester: induction of IgM secretion and changes in the expression of B cell-associated surface antigens.

Authors:  J Gordon; H Mellstedt; P Aman; P Biberfeld; G Klein
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

Review 6.  Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications.

Authors:  H P Koeffler
Journal:  Blood       Date:  1983-10       Impact factor: 22.113

7.  Isoenzyme studies in human leukemia-lymphoma cells lines--II. Acid phosphatase.

Authors:  H G Drexler; G Gaedicke; J Minowada
Journal:  Leuk Res       Date:  1985       Impact factor: 3.156

8.  Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells.

Authors:  T H Tötterman; K Nilsson; C Sundström
Journal:  Nature       Date:  1980-11-13       Impact factor: 49.962

9.  Isoenzyme studies in human leukemia-lymphoma cell lines--III. beta-Hexosaminidase (E.C. 3.2.1.30).

Authors:  H G Drexler; G Gaedicke; J Minowada
Journal:  Leuk Res       Date:  1985       Impact factor: 3.156

10.  Cytochemical analysis of acid hydrolases expression during phorbol diester (TPA)-driven differentiation of B-chronic lymphocytic leukaemia cells in vitro.

Authors:  J Dufer; J Bernard
Journal:  Leuk Res       Date:  1984       Impact factor: 3.156

View more
  2 in total

1.  Tartrate resistant acid phosphatase positive splenic lymphoma: a relatively benign condition occurring in a time-space cluster?

Authors:  P Kettle; T C Morris; G M Markey; H D Alexander; R C Curry; D Hayes; C H Cameron; P G Toner
Journal:  J Clin Pathol       Date:  1990-09       Impact factor: 3.411

2.  Body mass index and annual increase of body mass index in long-term childhood cancer survivors; relationship to treatment.

Authors:  Cornelia A J Brouwer; Jourik A Gietema; Judith M Vonk; W J E Tissing; Hendrika M Boezen; Nynke Zwart; Aleida Postma
Journal:  Support Care Cancer       Date:  2011-01-15       Impact factor: 3.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.